Literature DB >> 8735338

Varicella zoster infections in children with acute lymphoblastic leukemia.

A Poulsen1, K Schmiegelow, M Yssing.   

Abstract

During the period July 1986 through December 1991, 67 children were treated for non-B-cell acute lymphoblastic leukemia at The Juliane Marie Centre, GGK, The University Hospital Rigshospitalet, Copenhagen. Twenty-five children were susceptible to varicella zoster (VZ) virus at diagnosis. For these patients the cumulated risk of VZ exposure was 90% after 32 months. Five patients developed varicella (two of whom had pneumonitis) during the period of antileukemic treatment. Two of these had received prophylactic treatment with acyclovir. The 2 year cumulated risk of having chickenpox or herpes zoster in children with previous VZ infection was 24% and 34%, respectively. VZ vaccination ought to be considered for this group of children in order to diminish transmission and morbidity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735338     DOI: 10.3109/08880019609030821

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

Review 1.  Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation.

Authors:  Brian T Fisher; Sarah Alexander; Christopher C Dvorak; Theoklis E Zaoutis; Danielle M Zerr; Lillian Sung
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

2.  Increased risk of herpes zoster in children with cancer: A nationwide population-based cohort study.

Authors:  Hsiao-Chuan Lin; Yu-Hua Chao; Kang-Hsi Wu; Ting-Yu Yen; Yu-Lung Hsu; Tsung-Hsueh Hsieh; Hsiu-Mei Wei; Jhong-Lin Wu; Chih-Hsin Muo; Kao-Pin Hwang; Ching-Tien Peng; Cheng-Chieh Lin; Tsai-Chung Li
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

3.  The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study.

Authors:  H T Sørensen; J H Olsen; P Jepsen; S P Johnsen; H C Schønheyder; L Mellemkjaer
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.